Skip to main content
Proceedings of the Royal Society B: Biological Sciences logoLink to Proceedings of the Royal Society B: Biological Sciences
. 1999 Mar 7;266(1418):493–498. doi: 10.1098/rspb.1999.0664

Lineage selection and the evolution of multistage carcinogenesis.

L Nunney 1
PMCID: PMC1689794  PMID: 10189713

Abstract

A wide array of proto-oncogenes and tumour suppressor genes are involved in the prevention of cancer. Each form of cancer requires mutations in a characteristic group of genes, but no single group controls all cancers. This lack of generality shows that the control of cancer is not an ancient, fixed property of cells. By contrast, it supports a dynamic evolutionary model, whereby genetic controls over unregulated cell growth are recruited independently through evolutionary time in different tissues within different taxa. The complexity of this genetic control can be predicted from a population genetic model of lineage selection driven by the detrimental fitness effects of cancer. Cancer occurs because the genetic control of cell growth is vulnerable to somatic mutations (or 'hits'), particularly in large, continuously dividing tissues. Thus, compared to small rodents, humans must have evolved more complex genetic controls over cell growth in at least some of their tissues because of their greater size and longevity; an expectation relevant to the application of mouse data to humans. Similarly, the 'two-hit' model so successfully applied to retinoblastoma, which originates in a small embryonic tissue, is unlikely to be generally applicable to other human cancers; instead, more complex scenarios are expected to dominate, with complexity depending upon a tissue's size and its pattern of proliferation.

Full Text

The Full Text of this article is available as a PDF (223.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ARMITAGE P., DOLL R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer. 1954 Mar;8(1):1–12. doi: 10.1038/bjc.1954.1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Brash D. E. Sunlight and the onset of skin cancer. Trends Genet. 1997 Oct;13(10):410–414. doi: 10.1016/s0168-9525(97)01246-8. [DOI] [PubMed] [Google Scholar]
  3. Cairns J. Mutation selection and the natural history of cancer. Nature. 1975 May 15;255(5505):197–200. doi: 10.1038/255197a0. [DOI] [PubMed] [Google Scholar]
  4. Clarkson B. D., Strife A., Wisniewski D., Lambek C., Carpino N. New understanding of the pathogenesis of CML: a prototype of early neoplasia. Leukemia. 1997 Sep;11(9):1404–1428. doi: 10.1038/sj.leu.2400751. [DOI] [PubMed] [Google Scholar]
  5. Frame S., Crombie R., Liddell J., Stuart D., Linardopoulos S., Nagase H., Portella G., Brown K., Street A., Akhurst R. Epithelial carcinogenesis in the mouse: correlating the genetics and the biology. Philos Trans R Soc Lond B Biol Sci. 1998 Jun 29;353(1370):839–845. doi: 10.1098/rstb.1998.0248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Frank S. A. Mutual policing and repression of competition in the evolution of cooperative groups. Nature. 1995 Oct 12;377(6549):520–522. doi: 10.1038/377520a0. [DOI] [PubMed] [Google Scholar]
  7. Goodrow T. L. One decade of comparative molecular carcinogenesis. Prog Clin Biol Res. 1996;395:57–80. [PubMed] [Google Scholar]
  8. Hamilton W. D. The genetical evolution of social behaviour. II. J Theor Biol. 1964 Jul;7(1):17–52. doi: 10.1016/0022-5193(64)90039-6. [DOI] [PubMed] [Google Scholar]
  9. Hethcote H. W., Knudson A. G., Jr Model for the incidence of embryonal cancers: application to retinoblastoma. Proc Natl Acad Sci U S A. 1978 May;75(5):2453–2457. doi: 10.1073/pnas.75.5.2453. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Hunter T. Cooperation between oncogenes. Cell. 1991 Jan 25;64(2):249–270. doi: 10.1016/0092-8674(91)90637-e. [DOI] [PubMed] [Google Scholar]
  11. Knudson A. G., Jr Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci U S A. 1971 Apr;68(4):820–823. doi: 10.1073/pnas.68.4.820. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Loeb L. A. Mutator phenotype may be required for multistage carcinogenesis. Cancer Res. 1991 Jun 15;51(12):3075–3079. [PubMed] [Google Scholar]
  13. McKean K. A., Zuk M. An evolutionary perspective on signaling in behavior and immunology. Naturwissenschaften. 1995 Nov;82(11):509–516. doi: 10.1007/BF01134486. [DOI] [PubMed] [Google Scholar]
  14. Shackney S. E., Shankey T. V. Common patterns of genetic evolution in human solid tumors. Cytometry. 1997 Sep 1;29(1):1–27. [PubMed] [Google Scholar]
  15. Strauss B. S. Hypermutability in carcinogenesis. Genetics. 1998 Apr;148(4):1619–1626. doi: 10.1093/genetics/148.4.1619. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Wright S. Evolution in Mendelian Populations. Genetics. 1931 Mar;16(2):97–159. doi: 10.1093/genetics/16.2.97. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society B: Biological Sciences are provided here courtesy of The Royal Society

RESOURCES